The Centre has stepped in to procure vaccines from United States (US)-based Pfizer and Moderna Inc after the two companies refused to directly supply vaccines to Punjab and Delhi Governments, Livemint.
Sharing details about this yesterday (24 May), Lav Agarwal who is the Joint Secretary at the Union Ministry of Health said that the Centre is coordinating with them and is facilitating them in terms of approval and procurement.
Agarwal also added that the order book of Pfizer and Moderna is full so it depends on their surplus that how much they can provide to India. He said that the two companies will come back on it to the Centre and that the Centre will help in facilitation to States.
Meanwhile, India has so far been running the ongoing nationwide COVID-19 vaccination drive with supplies of Covishield from Pune based Serum Institute of India (SII) and supplies of Covaxin from Hyderabad based Bharat Biotech. Efforts are in the process to ramp up the production of both the vaccines in the near term to meet the surge in demand and need.
As you are no doubt aware, Swarajya is a media product that is directly dependent on support from its readers in the form of subscriptions. We do not have the muscle and backing of a large media conglomerate nor are we playing for the large advertisement sweep-stake.
Our business model is you and your subscription. And in challenging times like these, we need your support now more than ever.
We deliver over 10 - 15 high quality articles with expert insights and views. From 7AM in the morning to 10PM late night we operate to ensure you, the reader, get to see what is just right.
Becoming a Patron or a subscriber for as little as Rs 1200/year is the best way you can support our efforts.